Literature DB >> 28657232

Serum Prolactin and Cardiac Remodeling in Subjects with Prediabetes.

Jin Hwa Kim1.   

Abstract

Entities:  

Year:  2017        PMID: 28657232      PMCID: PMC5489496          DOI: 10.4093/dmj.2017.41.3.168

Source DB:  PubMed          Journal:  Diabetes Metab J        ISSN: 2233-6079            Impact factor:   5.376


× No keyword cloud information.
Prolactin is an anterior pituitary hormone, and its most well-known physiological role is to control initiation and maintenance of lactation [1]. Recently, its other broad physiological functions including metabolism were suggested, as the expression of prolactin receptor was found in various organs such as endometrium, prostate, pancreatic islets, and adipose tissue [23]. Previous studies showed that prolactin has effects on obesity, insulin resistance, and the growth of pancreatic β-cells, which may mediate diabetes [145]. Several studies suggested an inverse association between serum prolactin levels and metabolic parameters such as cardiovascular events, cardiac remodeling, diabetes, metabolic syndrome, and adverse lipid profiles [678]. Furthermore, studies on serum prolactin levels within the physiological range revealed conflicting results. This article entitled “Impact of gender on the association between low serum prolactin and left ventricular mass in subjects with prediabetes,” along with that published by El-Eshmawy et al. [9], evaluated the association between serum prolactin level and cardiac remodeling in patients with prediabetes according to gender. It is helpful that the association between serum prolactin levels and other parameters were evaluated separately for each gender, as serum prolactin levels can be regulated differently between genders. Estrogen is believed to play a central role in the control of prolactin release. In this study, physiologically low serum prolactin was an independent predictor of increased left ventricular mass and left ventricular hypertrophy in adult men, but not in women. Determining the exact biologic mechanism underlying these differences was not possible because it was a cross sectional study. However, this approach is quite valuable in establishing a potential gender-specific diagnostic biomarker for cardiac remodeling in patients with prediabetes. The authors have clearly shown their results in this manuscript. In my opinion, it would have added more value to their findings if they measured and adjusted for the effect of sex hormones and sex hormone-binding globulins as a potential confounding factors, which would have demonstrated the results more clearly.
  8 in total

1.  Ontogenesis of prolactin receptors in the human fetus in early gestation. Implications for tissue differentiation and development.

Authors:  M Freemark; P Driscoll; R Maaskant; A Petryk; P A Kelly
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

2.  Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue.

Authors:  Louise Nilsson; Nadine Binart; Mohammad Bohlooly-Y; Margareta Bramnert; Emil Egecioglu; Jon Kindblom; Paul A Kelly; John J Kopchick; Christopher J Ormandy; Charlotte Ling; Håkan Billig
Journal:  Biochem Biophys Res Commun       Date:  2005-06-17       Impact factor: 3.575

3.  Sex-specific associations of serum prolactin concentrations with cardiac remodeling: longitudinal results from the Study of Health Pomerania (SHIP).

Authors:  Robin Haring; Henry Völzke; Ramachandran S Vasan; Stephan B Felix; Matthias Nauck; Marcus Dörr; Henri Wallaschofski
Journal:  Atherosclerosis       Date:  2012-01-13       Impact factor: 5.162

4.  Neuroanatomical specificity of prolactin-induced hyperphagia in virgin female rats.

Authors:  D Sauvé; B Woodside
Journal:  Brain Res       Date:  2000-06-23       Impact factor: 3.252

Review 5.  Adipocyte prolactin: regulation of release and putative functions.

Authors:  T Brandebourg; E Hugo; N Ben-Jonathan
Journal:  Diabetes Obes Metab       Date:  2007-07       Impact factor: 6.577

Review 6.  What can we learn from rodents about prolactin in humans?

Authors:  Nira Ben-Jonathan; Christopher R LaPensee; Elizabeth W LaPensee
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

7.  Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes?

Authors:  Lisa Balbach; Henri Wallaschofski; Henry Völzke; Matthias Nauck; Marcus Dörr; Robin Haring
Journal:  BMC Endocr Disord       Date:  2013-03-21       Impact factor: 2.763

8.  Circulating prolactin associates with diabetes and impaired glucose regulation: a population-based study.

Authors:  Tiange Wang; Jieli Lu; Yu Xu; Mian Li; Jichao Sun; Jie Zhang; Baihui Xu; Min Xu; Yuhong Chen; Yufang Bi; Weiqing Wang; Guang Ning
Journal:  Diabetes Care       Date:  2013-01-22       Impact factor: 19.112

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.